Who benefits from classifying obesity as a disease?

1

Eli Lilly and Novo Nordisk assert that obesity is a chronic medical condition, not just a risk factor for other diseases.
2

The American Medical Association concluded there was insufficient evidence to classify obesity as a disease despite a membership vote favoring the designation.
3

Disease classification influences research funding, clinical attention, and insurance coverage, impacting how obesity is perceived and treated.
4

GLP-1 drugs like semaglutide provide significant weight loss and cardiovascular benefits but may shift focus away from behavioral and environmental interventions.
5

Framing obesity as a disease may overlook broader societal factors and risks, including long-term treatment dependence and misuse of medications.

1